Is an elevated Triglyceride-Glucose index associated with adverse metabolic and pregnancy outcomes in Chinese women with Polycystic Ovary Syndrome?
The TyG index may serve as a useful biomarker for identifying metabolic dysfunction and risk stratification in the management of PCOS.
Elevated TyG index strongly associates with adverse metabolic trajectories, and adverse pregnancy outcomes in PCOS patients. This biomarker shows particular utility for identifying metabolic dysfunction, suggesting clinical potential for risk stratification in PCOS management.
Feng et al. (Tue,) studied this question.